These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15113360)

  • 1. Improving liver allocation: MELD and PELD.
    Freeman RB; Wiesner RH; Roberts JP; McDiarmid S; Dykstra DM; Merion RM
    Am J Transplant; 2004; 4 Suppl 9():114-31. PubMed ID: 15113360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in liver transplantation before and after introduction of the MELD score.
    Moylan CA; Brady CW; Johnson JL; Smith AD; Tuttle-Newhall JE; Muir AJ
    JAMA; 2008 Nov; 300(20):2371-8. PubMed ID: 19033587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of MELD on OPTN liver allocation: preliminary results.
    Edwards EB; Harper AM
    Clin Transpl; 2002; ():21-8. PubMed ID: 12971434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MELD/PELD: one year later.
    Freeman RB
    Transplant Proc; 2003 Nov; 35(7):2425-7. PubMed ID: 14611977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA.
    Olthoff KM; Brown RS; Delmonico FL; Freeman RB; McDiarmid SV; Merion RM; Millis JM; Roberts JP; Shaked A; Wiesner RH; Lucey MR
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):A6-22. PubMed ID: 15382225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of pediatric candidates under the PELD system.
    McDiarmid SV; Merion RM; Dykstra DM; Harper AM
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S23-30. PubMed ID: 15384170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical analysis of the pediatric end-stage liver disease scoring system: a single center experience.
    Shneider BL; Neimark E; Frankenberg T; Arnott L; Suchy FJ; Emre S
    Liver Transpl; 2005 Jul; 11(7):788-795. PubMed ID: 15973720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection.
    Freeman RB
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S2-3. PubMed ID: 15382218
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of broader regional sharing of livers: 2-year results of "Share 35".
    Edwards EB; Harper AM; Hirose R; Mulligan DC
    Liver Transpl; 2016 Apr; 22(4):399-409. PubMed ID: 26890858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELD and PELD: application of survival models to liver allocation.
    Wiesner RH; McDiarmid SV; Kamath PS; Edwards EB; Malinchoc M; Kremers WK; Krom RA; Kim WR
    Liver Transpl; 2001 Jul; 7(7):567-80. PubMed ID: 11460223
    [No Abstract]   [Full Text] [Related]  

  • 13. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
    Shneider BL; Suchy FJ; Emre S
    Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waiting list outcome of Peld/Meld exceptions: A single-center experience in Argentina.
    Lauferman L; Dip M; Halac E; Cervio G; Aredes D; Capparelli M; Reijenstein H; Minetto J; Rojas L; Goñi J; Jacobo Dillon A; Martinitto R; Imventarza O
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29297966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End-Stage Liver Disease Scores and Exception Statuses.
    Wey A; Noreen S; Gentry S; Cafarella M; Trotter J; Salkowski N; Segev D; Israni A; Kasiske B; Hirose R; Snyder J
    Liver Transpl; 2022 Mar; 28(3):363-375. PubMed ID: 34482614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of PELD on OPTN liver allocation: preliminary results.
    Davies DB
    Clin Transpl; 2003; ():13-20. PubMed ID: 15387095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in access to liver transplantation: disease severity, waiting time, and transplantation center volume.
    Ahmad J; Bryce CL; Cacciarelli T; Roberts MS
    Ann Intern Med; 2007 May; 146(10):707-13. PubMed ID: 17502631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
    Silberhumer GR; Hetz H; Rasoul-Rockenschaub S; Peck-Radosavljevic M; Soliman T; Steininger R; Muehlbacher F; Berlakovich GA
    Transpl Int; 2006 Apr; 19(4):275-81. PubMed ID: 16573542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waiting list removal rates among patients with chronic and malignant liver diseases.
    Freeman RB; Edwards EB; Harper AM
    Am J Transplant; 2006 Jun; 6(6):1416-21. PubMed ID: 16686765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.